Cargando…

A Component Formula of Chinese Medicine for Hypercholesterolemia Based on Virtual Screening and Biology Network

Hypercholesterolemia is a risk factor to atherosclerosis and coronary heart disease II. The abnormal rise of cholesterol in plasma is the main symptom. Cholesterol synthesis pathway is an important pathway of the origin of cholesterol, which is an essential pathway for the therapy of hypercholestero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huo, Xiaoqian, Lu, Fang, Qiao, Liansheng, Li, Gongyu, Zhang, Yanling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046189/ https://www.ncbi.nlm.nih.gov/pubmed/30050582 http://dx.doi.org/10.1155/2018/1854972

Ejemplares similares

Virtual Screening for Potential Allosteric Inhibitors of Cyclin-Dependent Kinase 2 from Traditional Chinese Medicine
por: Lu, Fang, et al.
Publicado: (2016)

Discovery of Potential Inhibitors of Squalene Synthase from Traditional Chinese Medicine Based on Virtual Screening and In Vitro Evaluation of Lipid-Lowering Effect
por: Chen, Yankun, et al.
Publicado: (2018)

In Silico Analysis of the Association Relationship between Neuroprotection and Flavors of Traditional Chinese Medicine Based on the mGluRs
por: Zhang, Xu, et al.
Publicado: (2018)

Virtual Screening and Molecular Dynamics Study of Potential Negative Allosteric Modulators of mGluR1 from Chinese Herbs
por: Jiang, Ludi, et al.
Publicado: (2015)

Discovery of Anti-Hypertensive Oligopeptides from Adlay Based on In Silico Proteolysis and Virtual Screening
por: Qiao, Liansheng, et al.
Publicado: (2016)

Discovery of Novel Multi-target Inhibitor of angiotensin type 1 receptor and neprilysin inhibitors from Traditional Chinese Medicine
por: Huo, Xiaoqian, et al.
Publicado: (2019)

Discovery of Potential Inhibitors of Aldosterone Synthase from Chinese Herbs Using Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation Studies
por: Luo, Ganggang, et al.
Publicado: (2016)

ITPI: Initial Transcription Process-Based Identification Method of Bioactive Components in Traditional Chinese Medicine Formula
por: Zhang, Baixia, et al.
Publicado: (2016)

GEPSI: A Gene Expression Profile Similarity-Based Identification Method of Bioactive Components in Traditional Chinese Medicine Formula
por: Zhang, Baixia, et al.
Publicado: (2018)

Alternative Perspectives: How Chinese Medicine Understands Hypercholesterolemia
por: O'Brien, Kylie A.
Publicado: (2010)

Identification of Multi-Target Anti-AD Chemical Constituents From Traditional Chinese Medicine Formulae by Integrating Virtual Screening and In Vitro Validation
por: Zhang, Baoyue, et al.
Publicado: (2021)

The Mechanism Research of Qishen Yiqi Formula by Module-Network Analysis
por: Zheng, Shichao, et al.
Publicado: (2015)

Pharmacodynamics, Network Pharmacology, and Pharmacokinetics of Chinese Medicine Formula 9002A in the Treatment of Alzheimer’s Disease
por: Tang, Chunlan, et al.
Publicado: (2022)

Metabolomic Approach to Screening Homozygotes in Chinese Patients with Severe Familial Hypercholesterolemia
por: Du, Zhiyong, et al.
Publicado: (2023)

Uroporphyrinogen Decarboxylase as a Potential Target for Specific Components of Traditional Chinese Medicine: A Virtual Screening and Molecular Dynamics Study
por: Tsou, Yung-An, et al.
Publicado: (2012)

dTGS: Method for Effective Components Identification from Traditional Chinese Medicine Formula and Mechanism Analysis
por: Luo, Ji, et al.
Publicado: (2013)

Antioxidant activity and components of a traditional chinese medicine formula consisting of Crataegus pinnatifida and Salvia miltiorrhiza
por: Chen, Cheng-Yu, et al.
Publicado: (2013)

Construction Formula of Biological Age Using the Principal Component Analysis
por: Jia, Linpei, et al.
Publicado: (2016)

Chinese Medicines in the Treatment of Prostate Cancer: From Formulas to Extracts and Compounds
por: Wang, Xueni, et al.
Publicado: (2018)

The combination of UHPLC-HRMS and molecular networking improving discovery efficiency of chemical components in Chinese Classical Formula
por: Xue, Xiaoxia, et al.
Publicado: (2021)

Screening and verifying the mutations in the LDLR and APOB genes in a Chinese family with familial hypercholesterolemia
por: Lv, Xian, et al.
Publicado: (2023)

A Discovery Strategy for Active Compounds of Chinese Medicine Based on the Prediction Model of Compound-Disease Relationship
por: Huo, Mengqi, et al.
Publicado: (2022)

Systems biology approaches in the study of Chinese herbal formulae
por: Cai, Fei-Fei, et al.
Publicado: (2018)

Cascade Screening for Familial Hypercholesterolemia (FH)
por: Ned, Renée M., et al.
Publicado: (2011)

Treatment of hypercholesterolemia: screening of Solanum macrocarpon Linn (Solanaceae) as a medicinal plant in Benin
por: Dougnon, Tamègnon Victorien, et al.
Publicado: (2014)

Development and Validation of a UPLC-MS/MS Method for the Quantification of Components in the Ancient Classical Chinese Medicine Formula of Guyinjian
por: Ge, Nan, et al.
Publicado: (2022)

Growth Inhibition and Induction of Apoptosis in SHG-44 Glioma Cells by Chinese Medicine Formula “Pingliu Keli”
por: Cao, Peng, et al.
Publicado: (2011)

Hepatoprotective Effects of a Functional Formula of Three Chinese Medicinal Herbs: Experimental Evidence and Network Pharmacology-Based Identification of Mechanism of Action and Potential Bioactive Components
por: Li, Sha, et al.
Publicado: (2018)

Mutation detection in Chinese patients with familial hypercholesterolemia
por: Du, Ran, et al.
Publicado: (2016)

Discovery of a Natural Syk Inhibitor from Chinese Medicine through a Docking-Based Virtual Screening and Biological Assay Study
por: Wang, Xing, et al.
Publicado: (2018)

Virtual Screening and Molecular Docking to Study the Mechanism of Chinese Medicines in the Treatment of Coronavirus Infection
por: Ping, Fan, et al.
Publicado: (2022)

Screening of differentially expressed genes in children with cerebral palsy and the construction of a network of the effective components of traditional Chinese medicine
por: Che, Yueping, et al.
Publicado: (2022)

Genetic screening for homozygous and heterozygous familial hypercholesterolemia
por: Izar, Maria C, et al.
Publicado: (2010)

Finding Importance for Universal Screening of Familial Hypercholesterolemia
por: Yokoyama, Shinji
Publicado: (2022)

AMFormulaS: an intelligent retrieval system for traditional Chinese medicine formulas
por: Cui, Yidi, et al.
Publicado: (2021)

Visualization of Traditional Chinese Medicine Formulas: Development and Usability Study
por: Wu, Zhiyue, et al.
Publicado: (2023)

Study on Incompatibility of Traditional Chinese Medicine: Evidence from Formula Network, Chemical Space, and Metabolism Room
por: Long, Wei, et al.
Publicado: (2013)

Identifying the Chinese Herbal Medicine Network and Core Formula for Allergic Rhinitis on a Real-World Database
por: Lu, Yen-Chu, et al.
Publicado: (2020)

Synergistic Network Pharmacology for Traditional Chinese Medicine Liangxue Tongyu Formula in Acute Intracerebral Hemorrhagic Stroke
por: Chen, Yang, et al.
Publicado: (2021)

Genetics, Screening, and Treatment of Familial Hypercholesterolemia: Experience Gained From the Implementation of the Vietnam Familial Hypercholesterolemia Registry
por: Truong, Thanh-Huong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4172ve29a4u73p6ae8qgo4vsa3